Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

CHINA POWER (02380) registered to issue 2 billion yuan worth of medium-term notes.

BRII-B(02137): Tengsheng Pharmaceutical and Vir have not reached a settlement regarding the claim.

POU SHENG INT'L (03813) appoints Leung Pui Yee as an independent non-executive director.
CHINA POWER (02380) registered to issue 2 billion yuan worth of medium-term notes.

BRII-B(02137): Tengsheng Pharmaceutical and Vir have not reached a settlement regarding the claim.

POU SHENG INT'L (03813) appoints Leung Pui Yee as an independent non-executive director.






